Trials that use: Odds ratio
New to this method? Read the tutorial →
5,976 results
- MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035): Complete Statistical AnalysisIndependent statistical analysis of MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention: Complete Statistical AnalysisIndependent statistical analysis of mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MM-RCTIndependent statistical analysis of Moving Mindfully for Freezing of Gait: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05923229).
- MMAIndependent statistical analysis of Men, Mood, and Attention Study: Examination of Alcohol, State Anger, and Emotion Regulation Sexual Aggression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MMRIndependent statistical analysis of A Comparative Study to Assess Efficacy of Intralesional MMR Vaccine and Intralesional Vitamin D3 in Treatment of Warts: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID: Complete Statistical AnalysisIndependent statistical analysis of MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00794508).
- Mobile Health Intervention for Active Tuberculosis: Complete Statistical AnalysisIndependent statistical analysis of Mobile Health Intervention for Active Tuberculosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03544476).
- Mobile Health Intervention to Identify Early Responders to Treatment in Adolescent Obesity: Complete Statistical AnalysisIndependent statistical analysis of Mobile Health Intervention to Identify Early Responders to Treatment in Adolescent Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MODERNIndependent statistical analysis of Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Modified Dakin’s Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Modifying Cervical Bishop Scoring System: Complete Statistical AnalysisIndependent statistical analysis of Modifying Cervical Bishop Scoring System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02314260).
- ModOSAIndependent statistical analysis of Evaluation of Modafinil vs Placebo for Treatment of Anesthesia Delayed Emergence in Obstructive Sleep Apnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MOHELIndependent statistical analysis of T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma: Complete Statistical AnalysisIndependent statistical analysis of Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01355679).
- Molecular-Guided Therapy for Childhood Cancer: Complete Statistical AnalysisIndependent statistical analysis of Molecular-Guided Therapy for Childhood Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02162732).
- Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG): Complete Statistical AnalysisIndependent statistical analysis of Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01182350).
- MOMSIndependent statistical analysis of Management of Myelomeningocele Study (MOMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00060606).
- MONARCH 1Independent statistical analysis of A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Monitoring of Symptoms and Cognitive Function Using Telehealth: Complete Statistical AnalysisIndependent statistical analysis of Monitoring of Symptoms and Cognitive Function Using Telehealth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03184701).
- Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma: Complete Statistical AnalysisIndependent statistical analysis of Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00549328).
- MORNDIABIndependent statistical analysis of Morbidity in Newly Diagnosed type2 Diabetes in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02002091).
- Morpheus LungIndependent statistical analysis of A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer): primary endpoint results, effect estimate with confidence interval,…
- Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness: Complete Statistical AnalysisIndependent statistical analysis of Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Motorized Continuous Cold Therapy Versus Standard Post-op Icing Protocol for Two Foot and Ankle Procedures: Complete Statistical AnalysisIndependent statistical analysis of Motorized Continuous Cold Therapy Versus Standard Post-op Icing Protocol for Two Foot and Ankle Procedures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Move For Your Health for Older Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of Move For Your Health for Older Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05582889).
- MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05780463).
- MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics: Complete Statistical AnalysisIndependent statistical analysis of MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MRI Guided SBRT for Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of MRI Guided SBRT for Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03778112).
- MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval,…
- MSC2015103B in Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of MSC2015103B in Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01453387).
- MSG-01Independent statistical analysis of Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MTBVACIndependent statistical analysis of Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Mu-Opioid Receptor Genetic Polymorphism and Intrathecal Analgesia: Complete Statistical AnalysisIndependent statistical analysis of Mu-Opioid Receptor Genetic Polymorphism and Intrathecal Analgesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00418015).
- MUCINIndependent statistical analysis of Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination: Complete Statistical AnalysisIndependent statistical analysis of Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04722003).
- Multi OIT to Test Immune Markers After Minimum Maintenance Dose: Complete Statistical AnalysisIndependent statistical analysis of Multi OIT to Test Immune Markers After Minimum Maintenance Dose: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03181009).
- Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube: Complete Statistical AnalysisIndependent statistical analysis of Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.: Complete Statistical AnalysisIndependent statistical analysis of Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint…
- Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED): primary endpoint results, effect estimate with confidence interval,…
- Multi-Component Intervention to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV: Complete Statistical AnalysisIndependent statistical analysis of Multi-Component Intervention to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Multicenter Clinical Observation PROMOS®: Complete Statistical AnalysisIndependent statistical analysis of Multicenter Clinical Observation PROMOS®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02280499).
- Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy: primary endpoint results, effect estimate with confidence interval,…